Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
12.79
-0.06 (-0.47%)
Mar 18, 2026, 3:56 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $20.54 million as of March 19, 2026. Its market cap has increased by 13.69% in one year.
Market Cap
20.54M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.79
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 20.54M, a decrease of -97.96%. That is a compound annual growth rate of -54.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 20.63M | -4.72% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 33.30M |
| Harvard Apparatus Regenerative Technology | 30.24M |
| Provectus Biopharmaceuticals | 24.17M |
| Zenith Capital | 23.96M |
| Anebulo Pharmaceuticals | 22.42M |
| EOM Pharmaceuticals Holdings | 21.51M |
| Inhibitor Therapeutics | 15.19M |
| Zeo ScientifiX | 15.07M |